Anna Lehman

1.1k total citations
8 papers, 66 citations indexed

About

Anna Lehman is a scholar working on Genetics, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Anna Lehman has authored 8 papers receiving a total of 66 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 3 papers in Molecular Biology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Anna Lehman's work include Genetics and Neurodevelopmental Disorders (4 papers), Genomics and Rare Diseases (3 papers) and Cardiomyopathy and Myosin Studies (2 papers). Anna Lehman is often cited by papers focused on Genetics and Neurodevelopmental Disorders (4 papers), Genomics and Rare Diseases (3 papers) and Cardiomyopathy and Myosin Studies (2 papers). Anna Lehman collaborates with scholars based in Canada, United States and Netherlands. Anna Lehman's co-authors include Corinne Fasquelle, Elise Brischoux‐Boucher, Daniel Guerrier, Claire Josse, Laura Arbour, Bouchra Boujemla, Adeline Jacquinet, Karine Morcel, S. Frederiksen and Aimé Lumaka and has published in prestigious journals such as Movement Disorders, Human Mutation and European Journal of Human Genetics.

In The Last Decade

Anna Lehman

6 papers receiving 66 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Lehman Canada 4 32 30 11 10 10 8 66
Gulnara Svyatova Kazakhstan 6 20 0.6× 27 0.9× 2 0.2× 19 1.9× 11 1.1× 26 84
Sophie Naudion France 6 37 1.2× 69 2.3× 8 0.7× 3 0.3× 2 0.2× 10 108
Kristin Boulier United States 2 20 0.6× 82 2.7× 9 0.8× 1 0.1× 7 0.7× 7 108
Mallory Owen United States 5 27 0.8× 66 2.2× 3 0.3× 3 0.3× 15 1.5× 8 103
Ziqi Xu United States 2 19 0.6× 81 2.7× 7 0.6× 1 0.1× 7 0.7× 2 103
Carol Gardiner United Kingdom 4 29 0.9× 18 0.6× 19 1.9× 9 0.9× 7 59
María Eugenia Rocha Germany 5 32 1.0× 34 1.1× 6 0.5× 2 0.2× 8 70
Melissa Crenshaw United States 6 27 0.8× 36 1.2× 23 2.1× 1 0.1× 6 0.6× 13 83
Dorothea Wand Germany 5 55 1.7× 17 0.6× 2 0.2× 2 0.2× 8 0.8× 9 78
Catherine L. Mercer United Kingdom 5 41 1.3× 49 1.6× 9 0.8× 7 0.7× 6 72

Countries citing papers authored by Anna Lehman

Since Specialization
Citations

This map shows the geographic impact of Anna Lehman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lehman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lehman more than expected).

Fields of papers citing papers by Anna Lehman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Lehman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lehman. The network helps show where Anna Lehman may publish in the future.

Co-authorship network of co-authors of Anna Lehman

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Lehman. A scholar is included among the top collaborators of Anna Lehman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Lehman. Anna Lehman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Mohajeri, Arezoo, Clara D.M. van Karnebeek, Gabriella Horváth, et al.. (2025). Disco‐Interacting Protein 2 Homolog B CGG Repeat Expansion in Siblings with Neurodevelopmental Disability and Progressive Movement Disorder. Movement Disorders. 40(3). 567–578.
2.
Lehman, Anna, et al.. (2025). Exploring associations between estrogen and gene candidates identified by coronary artery disease genome-wide association studies. Frontiers in Cardiovascular Medicine. 12. 1502985–1502985.
3.
Richmond, Phillip A., et al.. (2024). Naturally occurring splice variants dissect the functional domains of BHC80 and emphasize the need for RNA analysis. American Journal of Medical Genetics Part A. 194(6). e63548–e63548. 1 indexed citations
4.
Chalazan, Brandon, Arezoo Mohajeri, Prakash Krishnan, et al.. (2023). Genetic testing in monogenic early-onset atrial fibrillation. European Journal of Human Genetics. 31(7). 769–775. 9 indexed citations
5.
Udani, Rupa, Kala F. Schilter, Rebecca C. Tyler, et al.. (2023). A novel variant of TNNC1 associated with severe dilated cardiomyopathy causing infant mortality and stillbirth: a case of germline mosaicism. Journal of Genetics. 102(1). 2 indexed citations
6.
Frederiksen, S., et al.. (2022). Rare disorders have many faces: in silico characterization of rare disorder spectrum. Orphanet Journal of Rare Diseases. 17(1). 76–76. 13 indexed citations
7.
Jacquinet, Adeline, Bouchra Boujemla, Corinne Fasquelle, et al.. (2020). GREB1L variants in familial and sporadic hereditary urogenital adysplasia and Mayer‐Rokitansky‐Kuster‐Hauser syndrome. Clinical Genetics. 98(2). 126–137. 27 indexed citations
8.
Stevens, Servi J.C., Vyne van der Schoot, Magalie S. Leduc, et al.. (2018). De novo mutations in theSETnuclear proto-oncogene, encoding a component of the inhibitor of histone acetyltransferases (INHAT) complex in patients with nonsyndromic intellectual disability. Human Mutation. 39(7). 1014–1023. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026